Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 7Other hematologic neoplasm 5Sarcoma 4Gastrointestinal 4CNS 4Gynecologic 3Genitourinary 3Classical hematology 3Tumor-Agnostic 2Head & Neck 2Dermatologic 2Myeloid 1Endocrine 1

Conditions

Skin Neoplasms 1Recurrence 1Neoplasms 1Melanoma 1

Interventions

pembrolizumab 326Nivolumab 289Ipilimumab 260Cyclophosphamide 193aldesleukin 145Interleukin-2 109fludarabine phosphate 106Temozolomide 83Dacarbazine 81fludarabine 80Radiotherapy 74trametinib 73Vemurafenib 69dabrafenib 66Biopsy 65sargramostim 50Bevacizumab 50Radiosurgery 49Paclitaxel 49Peripheral Blood Stem Cell Transplantation 48Carboplatin 48Magnetic Resonance Spectroscopy 47Imiquimod 47Aminolevulinic Acid 47binimetinib 45Cisplatin 45CTLA-4 Antigen 43cemiplimab 42atezolizumab 41Specimen Handling 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Tranexamic Acid × Dermatologic × Clear all
NCT05899465 2025-03-18

PRIME

University of Aarhus

Phase 3 Recruiting
1,204 enrolled
Dermatologic

Melanoma, Neoplasms, Recurrence

NCT04630886 2024-11-19

Use of Tranexamic Acid in Reduction of Post-Op Complications in Mohs Micrographic Surgery

University of Massachusetts, Worcester

Phase EARLY_PHASE1 Terminated
34 enrolled
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡